Keyphrases
Acquired Resistance
100%
Breast Cancer Cells
100%
Estrogen Receptor Signaling
100%
Metformin
100%
Growth Pathway
100%
Estrogen Receptor
45%
Adenosine Monophosphate-activated Protein Kinase
36%
MCF-7
27%
Metformin Treatment
27%
Breast Cancer
18%
Mammalian Target of Rapamycin (mTOR)
18%
Cyclin D1 (CCND1)
18%
NF-B
18%
Cross-resistance
18%
E-cadherin
18%
Constitutive Activation
18%
Epidemiological Study
9%
Signaling Pathway
9%
Hyperglycemia
9%
Growth Inhibition
9%
Protein Expression
9%
Transcriptional Activity
9%
Protein Inhibition
9%
Immunoblotting
9%
Cancer Types
9%
Luciferase Reporter Gene
9%
Resistant Cells
9%
Anticancer Drugs
9%
Receptor Regulation
9%
Antitumor
9%
Resistant Phenotypes
9%
Type 2 Diabetic Patients
9%
Immunohistochemical Analysis
9%
Protein Kinase Activity
9%
MCF-7 Cells
9%
Phospho-Akt
9%
Biguanides
9%
D1 Receptor
9%
Antidiabetic Drugs
9%
Estrogen Receptor-positive
9%
Reporter Gene Analysis
9%
Growth-related
9%
Energy Sensor
9%
Cadherin Signaling
9%
Tamoxifen Resistance
9%
Non-sensitive
9%
Medicine and Dentistry
Breast Cancer
100%
Cancer Cell
100%
Estrogen Receptor
100%
Glycon
100%
Adenosine Phosphate
28%
MCF-7
28%
Protein Kinases
21%
Tamoxifen
21%
Neoplasm
14%
Cyclin D1
14%
Uvomorulin
14%
Mechanistic Target of Rapamycin
14%
Cross Resistance
14%
Malignant Neoplasm
7%
Hyperglycemia
7%
Signal Transduction
7%
Casein Kinase
7%
Antidiabetic Agent
7%
Protein Expression
7%
Reporter Gene
7%
Immunoblotting
7%
Patient with Type 2 Diabetes
7%
Biguanide
7%
Luciferase
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Estrogen Receptor
100%
Adenosine Monophosphate
57%
Protein Kinases
42%
Mechanistic Target of Rapamycin
28%
Cyclin D1
28%
Cross Resistance
28%
Cadherin
28%
Protein Expression
14%
Casein Kinase
14%
Signal Transduction
14%
Reporter Gene
14%
Hyperglycemia
14%
Luciferase
14%
Gene Analysis
14%
Immunoblotting
14%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Breast Cancer
100%
Metformin
100%
Adenosine Phosphate
28%
Protein Kinases
21%
Tamoxifen
21%
Neoplasm
14%
Mammalian Target of Rapamycin
14%
Cyclin D1
14%
Uvomorulin
14%
Cross-Resistance
14%
Malignant Neoplasm
7%
Hyperglycemia
7%
Western Blot
7%
Antidiabetic Agent
7%
Luciferase
7%
Casein Kinase
7%
Biguanide
7%
Non Insulin Dependent Diabetes Mellitus
7%
Immunology and Microbiology
Cancer Cell
100%
Cyclin D1
50%
Cross-Resistance
50%
Cadherin
50%
Sirolimus
50%
Signal Transduction
25%
Western Blot
25%
Reporter Gene
25%
Protein Expression
25%